PON1 and metabolic dysfunction-associated steatotic liver disease: The unchanged PON1 and ARE activities are significant, given their associations with increased oxidative stress and various systemic conditions, including neurodegenerative diseases, type 2 diabetes, NAFLD, CKD, and autoimmune disorders [22,23,24,25].